ClinicalTrials.Veeva

Menu

Use of a Smartphone Application on the Detection of Complications Related to Smoking (APPLITABAC)

W

Weprom

Status

Completed

Conditions

Tabagism
Chronic Obstructive Pulmonary Disease
Lung Cancer

Treatments

Device: Applitabac

Study type

Observational

Funder types

Other

Identifiers

NCT04048954
WP-2019-01
NR1512030619 (Other Identifier)

Details and patient eligibility

About

Smokers do not know the symptoms of cancer and wait on average 5 months with symptoms before consulting. 80% of lung cancers are diagnosed at too late and incurable stage.

Systematic CT screening of smokers is under evaluation and currently not supported because expensive and little used in real life (in the US 1.8% of smokers after 7 years of establishment in the USA).

An English study showed an increase in the number of operable stage cancers of 3% among smokers by calling them on a trailing cough by a simple poster campaign ("You smoke, you cough for more than 3 weeks, consult").

Regarding COPD, it is linked to tobacco in 85% of cases, affects 3.5 million French and is in 2013 the 4th leading cause of death in France. The evolution of COPD is marked by exacerbations, period of acute aggravation of symptoms, responsible for the deterioration of the quality of life or even hospitalization or death. COPD remains a silent killer responsible, according to this same summary review, of 16,500 deaths per year in France.

Dr DENIS has developed a web application that has shown a 7-month survival benefit by early detection of lung cancer relapses based on the reporting of patient symptoms analyzed by a validated algorithm in 300 patients and 1 randomized trial.

The Applitabac app takes this concept of symptom self-assessment by patients. By multiplying the number of symptoms analyzed compared to the English study, Applitabac should be able to increase the sensitivity of this early detection of COPD and increase the number of operable bronchial cancers and increase the chances of survival of patients.

Enrollment

5,671 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age >= 18 years old
  • Applitabac user who has received a notification directing him to his doctor
  • Smoker or former smoker (current smoking cessation or ≤ 5 years)
  • Patient informed of the use of his data and not opposing it

Exclusion criteria

  • Presence of another evolutionary neoplasia in the past 2 years
  • Patient who did not use the Applitabac app

Trial design

5,671 participants in 1 patient group

APPLITABAC arm
Description:
Use of a smartphone application on screening for complications related to tabagism
Treatment:
Device: Applitabac

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems